Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
ipratropium | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank , DGIDB | Expiration function[MeSHID:D045853] Sialorrhea[MeSHID:D012798] Sneezing[MeSHID:D012912] Drinking Water[MeSHID:D060766] Nose[MeSHID:D009666] Patient Discharge[MeSHID:D010351] Recurrence (disease attribute)[MeSHID:D012008] Pulmonary Emphysema[MeSHID:D011656] Dyspnea[MeSHID:D004417] Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Bronchial Spasm[MeSHID:D001986] Asthma[MeSHID:D001249] Chronic Obstructive Airway Disease[MeSHID:D029424] Disease[MeSHID:D004194] Hay fever[MeSHID:D006255] Pathological accumulation of air in tissues[MeSHID:D004646] Comprehension[MeSHID:D032882] Common Cold[MeSHID:D003139] Bronchitis Chronic[MeSHID:D029481] Unmarried[MeSHID:D012847] Inspiration function[MeSHID:D001239] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lung Diseases Obstructive[MeSHID:D008173] |
0.38 | approved,experimental | antagonist |
ipratropium | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank , DGIDB | Expiration function[MeSHID:D045853] Sialorrhea[MeSHID:D012798] Sneezing[MeSHID:D012912] Drinking Water[MeSHID:D060766] Nose[MeSHID:D009666] Patient Discharge[MeSHID:D010351] Recurrence (disease attribute)[MeSHID:D012008] Pulmonary Emphysema[MeSHID:D011656] Dyspnea[MeSHID:D004417] Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Bronchial Spasm[MeSHID:D001986] Asthma[MeSHID:D001249] Chronic Obstructive Airway Disease[MeSHID:D029424] Disease[MeSHID:D004194] Hay fever[MeSHID:D006255] Pathological accumulation of air in tissues[MeSHID:D004646] Comprehension[MeSHID:D032882] Common Cold[MeSHID:D003139] Bronchitis Chronic[MeSHID:D029481] Unmarried[MeSHID:D012847] Inspiration function[MeSHID:D001239] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lung Diseases Obstructive[MeSHID:D008173] |
0.51 | approved,experimental | antagonist |
ipratropium | muscarinic acetylcholine receptor m3 | small molecule | Successful target | TTD , drugbank , DGIDB | Expiration function[MeSHID:D045853] Sialorrhea[MeSHID:D012798] Sneezing[MeSHID:D012912] Drinking Water[MeSHID:D060766] Nose[MeSHID:D009666] Patient Discharge[MeSHID:D010351] Recurrence (disease attribute)[MeSHID:D012008] Pulmonary Emphysema[MeSHID:D011656] Dyspnea[MeSHID:D004417] Disease Management[MeSHID:D019468] Maintenance[MeSHID:D008283] Bronchial Spasm[MeSHID:D001986] Asthma[MeSHID:D001249] Chronic Obstructive Airway Disease[MeSHID:D029424] Disease[MeSHID:D004194] Hay fever[MeSHID:D006255] Pathological accumulation of air in tissues[MeSHID:D004646] Comprehension[MeSHID:D032882] Common Cold[MeSHID:D003139] Bronchitis Chronic[MeSHID:D029481] Unmarried[MeSHID:D012847] Inspiration function[MeSHID:D001239] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lung Diseases Obstructive[MeSHID:D008173] |
0.35 | approved,experimental | antagonist |
click here to return to the previous page |